MacDonald Dettwiler is fairly valued, says Cormark

Following a quarter that was in-line with his expectations, Cormark Securities analyst Richard Tse says shares of MacDonald Dettwiler (MacDonald Dettwiler Stock Quote, Chart, News: TSX:MDA) are fairly valued.

Yesterday, MDA reported its Q1, 2016 results. The company earned $40.7-million on revenue of $562-million, a topline that was up 5.3 per cent from the same period last year.

Tse says MDA’s revenue was directly in line with what he had modeled and earnings were just a penny short. The analyst says he believes the stock is currently close to fair value, but says some positives could occur later this year that might change his opinion.

“We continue to believe the stock is close to fair value,” says Tse. “That said, given the heightened bid activity, we believe the potential for an outsized lift in bookings could have us revisiting our rating – but we currently don’t expect much visibility on that until H2/F16. While MDA had momentum exiting 2015, our tracking of global awards across the industry YTD suggests a slow start to the year which we believe was corroborated by MDA Management on its conference call last night when it pointed to the bulk awards expected to occur in H2/16 (similar to 2015). At the same time, with the appointment of a new President and CEO (Howard Lance), there’s also the risk of a potential pause from the changeover.”

In a research update to clients today, Tse maintained his “Market Perform” rating and one-year price target of $90.00 on Macdonald Dettwiler.

More Cantech Hardware

Tagged with: mda
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Universal Display Corp a buy right now?

In an April 1 report, Roth Capital Markets analyst Scott Searle maintained his “Buy” rating and $180.00 target on Universal… [Read More]

3 days ago

This analyst loves NervGen Pharma

In a March 31 report, Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and US$5.50 target on NervGen… [Read More]

3 days ago

NTG Clarity Networks is a buy, this analyst says

In a March 31 initiation, Ventum Capital Markets analyst Amr Ezzat launched coverage of NTG Clarity Networks (NTG Clarity Networks… [Read More]

3 days ago

Uber is much more than you think, this investor says

In an appearance on BNN Bloomberg Market Call on March 31, Propellus Wealth Partners portfolio manager and senior wealth advisor… [Read More]

4 days ago

Canadian economy is on firmer footing than expected: RBC

In a March 31 report, RBC economist Abbey Xu said the Canadian economy started 2026 on firmer footing than expected,… [Read More]

4 days ago

Should you sell your zSpace stock?

In a March 31 report, Roth Capital Markets analyst Rohit Kulkarni maintained his “Buy” rating on zSpace (zSpace Stock Quote,… [Read More]

4 days ago